Susquehanna International Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-35,092
| Closed | -$30.1K | – | 6887 |
|
|
2023
Q4 | $30.1K | Sell |
35,092
-48,580
| -58% | -$41.7K | ﹤0.01% | 5620 |
|
|
2023
Q3 | $89.5K | Buy |
83,672
+24,831
| +42% | +$26.6K | ﹤0.01% | 4971 |
|
|
2023
Q2 | $152K | Sell |
58,841
-7,582
| -11% | -$19.6K | ﹤0.01% | 4797 |
|
|
2023
Q1 | $271K | Buy |
+66,423
| New | +$271K | ﹤0.01% | 4529 |
|
|
2022
Q4 | – | Sell |
-11,768
| Closed | -$154K | – | 7015 |
|
|
2022
Q3 | $154K | Sell |
11,768
-851
| -7% | -$11.1K | ﹤0.01% | 4996 |
|
|
2022
Q2 | $162K | Buy |
+12,619
| New | +$162K | ﹤0.01% | 4716 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6602 |
|
|
2021
Q3 | – | Sell |
-14,047
| Closed | -$277K | – | 6265 |
|
|
2021
Q2 | $277K | Buy |
+14,047
| New | +$277K | ﹤0.01% | 4546 |
|
|
2021
Q1 | – | Sell |
-13,718
| Closed | -$416K | – | 5891 |
|
|
2020
Q4 | $416K | Buy |
13,718
+2,394
| +21% | +$72.6K | ﹤0.01% | 3595 |
|
|
2020
Q3 | $180K | Sell |
11,324
-809
| -7% | -$12.9K | ﹤0.01% | 3931 |
|
|
2020
Q2 | $240K | Buy |
12,133
+706
| +6% | +$14K | ﹤0.01% | 3559 |
|
|
2020
Q1 | $141K | Buy |
+11,427
| New | +$141K | ﹤0.01% | 3946 |
|